2,291 results on '"James, Stefan"'
Search Results
202. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study
203. Risk of recurrent ischaemic events after myocardial infarction in long-distance ski race participants
204. Thrombus aspiration in patients with large anterior myocardial infarction: A Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia trial substudy
205. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
206. High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non–ST-segment elevation myocardial infarction
207. ST-segment elevation myocardial infarction
208. Instantaneous Wave-Free Ratio versus Fractional Flow Reserve guided intervention (iFR-SWEDEHEART): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial
209. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary
210. THE AUTHORS REPLY.
211. ST2 and mortality in non–ST-segment elevation acute coronary syndrome
212. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
213. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
214. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes
215. Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR): Ultrathin drug-eluting stents in the real world
216. Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy
217. Physical Activity Is Associated With Lower Long-Term Incidence of Anxiety in a Population-Based, Large-Scale Study
218. Benchmarking observational analyses before using them to address questions trials cannot answer: an application to coronary thrombus aspiration
219. Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials
220. Short‐ and Long‐Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry
221. Bleeding avoidance strategies in percutaneous coronary intervention
222. Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease
223. Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI
224. Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr
225. Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries
226. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
227. Stroke: a rare but devastating procedural complication of PCI
228. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial
229. OPINION: Registry-based randomized clinical trials—a new clinical trial paradigm
230. Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial
231. Follow-up of ischaemic heart disease in patients with coeliac disease
232. Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus: A Report From the SCAAR (Swedish Angiography and Angioplasty Registry)
233. Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria
234. Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI): Elective cardiac invasive procedures during the COVID-19 outbreak
235. sj-pdf-1-ctj-10.1177_17407745211012438 – Supplemental material for Assessing the external validity of the VALIDATE-SWEDEHEART trial
236. Communicating test results from a general health checkup: the public’s preferences from a discrete choice experiment survey
237. Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
238. Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI Trial
239. Sex as a determinant of prehospital ECG in ST- and non-ST elevation myocardial infarction patients
240. Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes
241. Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials
242. Essential pharmacology of antithrombotic agents
243. Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy
244. Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis
245. Assessing the external validity of the VALIDATE-SWEDEHEART trial
246. Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?
247. Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study
248. Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
249. Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen Saturation
250. Which Antiplatelet Agent for Whom? Which Patient Populations Benefit Most from Novel Antiplatelet Agents (Ticagrelor, Prasugrel)?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.